首页> 外文期刊>Dose-response >The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes:
【24h】

The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes:

机译:两种亚洲糖尿病患者的亲水性和亲脂性他汀类药物疗法的长期疗效之间的不同心血管结果:

获取原文
       

摘要

Purpose: To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. Method: Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were divided into 2 cohorts on the basis of their statin use, namely hydrophilic statin and lipophilic statin. We used Cox proportional hazard regression models to analyze the risks of cardiovascular outcomes. Result: In this study, 12 896 patients used statin, including 4259 patients using hydrophilic statin and 8637 patients using lipophilic statin. With 12-year follow-up, higher incidence rate of coronary artery disease and stroke was noted in the lipophilic statin use instead of hydrophilic statin use. Conclusion: According to our long-term cohort study, hydrophilic statin use may be a better choice than lipophilic statin to reduce cardiovascular events in Asian diabetic patients.
机译:目的:评估亲水性和亲脂性他汀类药物疗法对亚洲糖尿病患者心血管结局的长期疗效。方法:根据他汀类药物的使用情况,将2000年1月至2011年12月期间新诊断的2型糖尿病病例分为2组,即亲水性他汀类药物和亲脂性他汀类药物。我们使用Cox比例风险回归模型分析了心血管预后的风险。结果:在这项研究中,有12例896例患者使用他汀类药物,包括4259例使用亲水性他汀类药物和8637例使用亲脂性他汀类药物。经过12年的随访,发现亲脂性他汀类药物代替亲水性他汀类药物的使用会增加冠心病和中风的发生率。结论:根据我们的长期队列研究,亲水性他汀类药物的使用可能比亲脂性他汀类药物减少亚洲糖尿病患者的心血管事件更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号